![](/img/cover-not-exists.png)
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study
Smolen, Josef S, Kay, Jonathan, Doyle, Mittie, Landewé, Robert, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jürgen, Murphy, Frederick T, Xu, Stephen, Zhou, Yiying, Hsia, Elizabeth CVolume:
17
Language:
english
Journal:
Arthritis Research & Therapy
DOI:
10.1186/s13075-015-0516-6
Date:
December, 2015
File:
PDF, 426 KB
english, 2015